Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Circ-TRIO promotes TNBC progression by regulating the miR-432-5p/CCDC58 axis
Zekun Wang, Yaming Li, H. J. Yang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 9
Open Access | Times Cited: 24

Showing 24 citing articles:

CircTRIM1 encodes TRIM1-269aa to promote chemoresistance and metastasis of TNBC via enhancing CaM-dependent MARCKS translocation and PI3K/AKT/mTOR activation
Yaming Li, Zekun Wang, H. J. Yang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 6
The mechanism underlying metastasis in triple-negative breast cancer: focusing on the interplay between ferroptosis, epithelial-mesenchymal transition, and non-coding RNAs
Ziyi Chen, Yi Zhao
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Regulatory network and targeted interventions for CCDC family in tumor pathogenesis
Zhen Liu, Weiwei Yan, Shaohua Liu, et al.
Cancer Letters (2023) Vol. 565, pp. 216225-216225
Closed Access | Times Cited: 19
CircZCCHC2 decreases pirarubicin sensitivity and promotes triple-negative breast cancer development via the miR-1200/TPR axis
Fan Zhang, Dexian Wei, Shishun Xie, et al.
iScience (2024) Vol. 27, Iss. 3, pp. 109057-109057
Open Access | Times Cited: 5
EIF4A3-mediated circ_0042881 activates the RAS pathway via miR-217/SOS1 axis to facilitate breast cancer progression
Chenxi Ju, Mingxia Zhou, Dan Du, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 8
Open Access | Times Cited: 12
CircCFL1 Promotes TNBC Stemness and Immunoescape via Deacetylation‐Mediated c‐Myc Deubiquitylation to Facilitate Mutant TP53 Transcription
Z.H Wang, Yaming Li, H. J. Yang, et al.
Advanced Science (2024)
Open Access | Times Cited: 4
CircRNA (circ)_0007823 Contributes to Triple-Negative Breast Cancer Progression and Cisplatin Resistance via the miR-182-5p/FOXO1 Pathway
Haofeng Wang, Xiaojie Wang, Weida Shen, et al.
Biochemical Genetics (2024)
Closed Access | Times Cited: 3
Circular RNAs in Breast Cancer: An Update
Haolin Bao, Jiehan Li, Qihang Zhao, et al.
Biomolecules (2024) Vol. 14, Iss. 2, pp. 158-158
Open Access | Times Cited: 2
Exploiting Long Non-Coding RNAs and Circular RNAs as Pharmacological Targets in Triple-Negative Breast Cancer Treatment
Alina Catalina Palcau, R. Brandi, Nikolay Mehterov, et al.
Cancers (2023) Vol. 15, Iss. 16, pp. 4181-4181
Open Access | Times Cited: 5
Molecular mechanisms of circular RNA in breast cancer: a narrative review
Zonglin Li, Rui Zhang, Donghai Li, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 2, pp. 1139-1149
Open Access | Times Cited: 1
The therapeutic potential of circular RNA in triple-negative breast cancer
Aiqi Xu, Lewei Zhu, Chengcai Yao, et al.
Cancer Drug Resistance (2024)
Open Access | Times Cited: 1
Myc derived circRNA promotes triple-negative breast cancer progression via reprogramming fatty acid metabolism
Shengting Wang, Yufang Wang, Yue Wang, et al.
Discover Oncology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Coiled-coil domain-containing protein 58 (CCDC58) is a novel prognostic biomarker correlated with mitochondrial functions in hepatocellular carcinoma.
Ling Chen, Jiaxin Zhang, Yulong Yang, et al.
PubMed (2023) Vol. 15, Iss. 4, pp. 2568-2584
Closed Access | Times Cited: 4
A pan-cancer analysis has uncovered CCDC58, a mitochondrial gene associated with epilepsy, as a potential prognostic and immunotherapeutic biomarker for various cancer types, including gliomas
Zhipeng You, Cong Huang, Jiran Li, et al.
Research Square (Research Square) (2024)
Open Access
YB-1 Targeted by miR-509-3-5p Affects Migration and Invasion of Triple‑Negative Breast Cancer by Regulating Cellular Epithelial‑Mesenchymal Transition
Hanzhi Dong, Zhiqiang Peng, Tenghua Yu, et al.
Molecular Biotechnology (2024)
Closed Access
EIF4A3-Bound hsa_circ_0006847 Exerts a Tumor-Suppressive Role in Gastric Cancer
Chuanxia Cao, Xinxin Wu, Zhe Li, et al.
DNA and Cell Biology (2024) Vol. 43, Iss. 5, pp. 232-244
Closed Access
CCDC58 is a potential biomarker for diagnosis, prognosis, immunity, and genomic heterogeneity in pan-cancer
Kai Yang, Yan Ma, Weigang Chen, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
CircRNA_0044556 affects the sensitivity of triple-negative breast cancer cells to paclitaxel by regulating miR-665
Jingjing Chen, Peng Shi, Zhi-chao Cui, et al.
Journal of Chemotherapy (2024), pp. 1-9
Open Access
CircDUSP16 mediates the effect of triple-negative breast cancer in pirarubicin via the miR-1224-3p/TFDP2 axis
Wei Dexian, Fan Zhang, Limin Ma, et al.
Biochemical Pharmacology (2024) Vol. 232, pp. 116719-116719
Closed Access
miR-432-5p Targeting SORT1 to Protect Artery Smooth Muscle Cells and Inhibit Coronary Artery Disease
Jinhe Chen, Fan Liu, Xianwei Meng
Biochemical Genetics (2024)
Closed Access
The Novel Circular RNA circTRIO Silence Inhibits the Progression of Laryngeal Squamous Cell Carcinoma
Jing Wang, Shujin He, Dingding Wang, et al.
DNA and Cell Biology (2023) Vol. 42, Iss. 7, pp. 421-432
Closed Access | Times Cited: 1
Circular RNA ATP2C1 (has_circ_0005797) sponges miR-432/miR-335 to promote breast cancer progression through regulating CCND1 expression.
Caiping Chen, Jianju Lu, Wang Li, et al.
PubMed (2023) Vol. 13, Iss. 8, pp. 3433-3448
Closed Access | Times Cited: 1
Comprehensive pan-cancer analysis reveals CCDC58 as a carcinogenic factor related to immune infiltration
Huili Wu, Qing Geng, Wenxiang Shi, et al.
APOPTOSIS (2023) Vol. 29, Iss. 3-4, pp. 536-555
Closed Access | Times Cited: 1
CircRNA_0044556 regulates paclitaxel resistance in triple-negative breast cancer by targeting miR-665
jingjing chen, Peng Shi, zhiqiang cui, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top